Nomura Micro Science (6254) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
3 Oct, 2025Executive summary
Achieved record-high order intake, sales, and profits in FY25, driven by large water treatment system projects in the US, South Korea, and Japan, with strong demand from the semiconductor sector and successful execution of the medium-term management plan.
Orders received increased 32.7% year-over-year, reflecting robust capital expenditure by major semiconductor customers and expansion into Southeast Asia and India.
Maintenance project orders and consumables sales grew, with smooth construction progress across regions.
Financial highlights
FY25 sales reached ¥96,359 million, up 32% year-over-year; operating income rose 44.4% to ¥15,372 million; net income attributable to shareholders was ¥10,199 million (+27.8% YoY).
Gross profit margin improved to 21.9%; operating income ratio increased to 16.0%.
Orders received grew 32.7% to ¥94,531 million; order backlog at year-end was ¥40,770 million.
Basic earnings per share: ¥270.75 (post-split); comprehensive income: ¥9,892 million (+15.5% YoY).
Cash and deposits increased to ¥17,330 million; total assets rose to ¥116,783 million.
Outlook and guidance
FY26 sales forecast at ¥60,000 million, a 37.7% decrease year-over-year, reflecting off-peak timing for large projects.
Operating income expected to decline 59.7% to ¥6,200 million; EPS forecast at ¥101.33; net income at ¥3,837 million (-62.4% YoY).
Orders received projected at ¥98,000–¥117,229 million, with continued strength in semiconductor capital investment and new large projects in South Korea and the US.
Dividend forecast for FY26: ¥70 per share (post-split basis).
Latest events from Nomura Micro Science
- Strong sales and profit growth fueled by semiconductor demand; outlook remains positive.6254
Q3 202613 Feb 2026 - Strong sales and profit growth fueled by semiconductor demand and water treatment projects.6254
Q2 202614 Nov 2025 - Net sales and profits fell sharply year-over-year, but full-year guidance remains unchanged.6254
Q1 20253 Oct 2025 - Sharp year-over-year declines in sales and profit, but full-year guidance remains unchanged.6254
Q2 20253 Oct 2025 - Sharp year-over-year declines, but strong FY2025 recovery forecast amid robust semiconductor demand.6254
Q3 20253 Oct 2025 - Revenue and profit soared on robust US and Japan demand; full-year outlook maintained.6254
Q1 20263 Oct 2025